Immunomedics is a biopharmaceutical company that specializes in developing monoclonal antibody-based products for the treatment of cancer and other serious diseases. Its corporate objective is to become a fully-integrated biopharmaceutical company. The company was founded in 1982 and headquartered in Morris Plains, New Jersey.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Immunomedics, Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Immunomedics, Inc. market cap is $20.31B.
What is the 52-week high for Immunomedics, Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Immunomedics, Inc. 52 week high is $87.93 as of September 28, 2025.
What is the 52-week low for Immunomedics, Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Immunomedics, Inc. 52 week low is $8.80 as of September 28, 2025.
What was Immunomedics, Inc. stock price yesterday?
Immunomedics, Inc. stock price yesterday was $87.86.
What is the PE ratio of Immunomedics, Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Immunomedics, Inc.’s P/E ratio is -51.04.
What is the Price-to-Book ratio of Immunomedics, Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Immunomedics, Inc. P/B ratio is 34.2001.
What is the 50-day moving average of Immunomedics, Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Immunomedics, Inc. 50-day moving average is $68.29.
